Literature DB >> 33037891

Effective apparent diffusion coefficient parameters for differentiation between mass-forming autoimmune pancreatitis and pancreatic ductal adenocarcinoma.

Hainan Ren1, Naoko Mori2, Shin Hamada3, Chiaki Takasawa1, Shunji Mugikura1, Atsushi Masamune3, Kei Takase1.   

Abstract

PURPOSE: To evaluate the diagnostic performance of apparent diffusion coefficient (ADC) parameters by region of interest (ROI) methods in differentiating mass-forming autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDAC).
METHODS: The institutional review board approved this retrospective study and the requirement for informed consent was waived. Twenty-three patients with mass-forming AIP and 144 patients with PDAC underwent diffusion-weighted imaging with b-values of 0 s/mm2 and 800 s/mm2. The minimum, maximum, and mean ADC values obtained by placing ROIs within lesions and percentile ADC values (10th, 25th, 50th, 75th, and 90th) from entire-lesion histogram analysis were compared between the two groups by using Mann-Whitney U tests. The diagnostic performance was evaluated by receiver operating characteristic (ROC) curve analysis.
RESULTS: The minimum, maximum, and mean ADC values were significantly different between mass-forming AIP and PDAC groups. ROC curve analysis showed that the maximum ADC had the highest diagnostic performance (0.92), while the minimum ADC value had the lowest diagnostic performance (0.72). The AUC of minimum ADC was significantly lower than that of maximum or mean ADC (P < 0.0001, P < 0.0001). The AUC was lowest in 10th percentile ADC value and highest in 90th percentile value. The AUC increased along with the increase of percentile values.
CONCLUSION: Either the maximum or mean ADC value was effective in differentiating mass-forming AIP from the PDAC group, while the minimum ADC value might not be recommended.

Entities:  

Keywords:  Apparent diffusion coefficient; Diffusion-weighted imaging; Magnetic resonance imaging; Mass-forming autoimmune pancreatitis; Pancreatic ductal adenocarcinoma

Year:  2020        PMID: 33037891     DOI: 10.1007/s00261-020-02795-x

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  3 in total

1.  Abnormal Findings on "T1WI or DWI or MRCP:" An Effective Boolean Interpretation Model in Discriminating Small Pancreatic Ductal Adenocarcinoma from Control Group.

Authors:  Hainan Ren; Naoko Mori; Minami Hirasawa; Shin Hamada; Shunji Mugikura; Atsushi Masamune; Kei Takase
Journal:  J Clin Imaging Sci       Date:  2021-10-12

2.  A systematic review of radiomics in pancreatitis: applying the evidence level rating tool for promoting clinical transferability.

Authors:  Jingyu Zhong; Yangfan Hu; Yue Xing; Xiang Ge; Defang Ding; Huan Zhang; Weiwu Yao
Journal:  Insights Imaging       Date:  2022-08-20

Review 3.  Imaging diagnosis of autoimmune pancreatitis: computed tomography and magnetic resonance imaging.

Authors:  Hiroshi Ogawa; Yasuo Takehara; Shinji Naganawa
Journal:  J Med Ultrason (2001)       Date:  2021-10-26       Impact factor: 1.314

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.